Greenhalgh, J 
ORCID: 0000-0003-4812-1904
(2017)
Sorafenib and lenvatinib for treating advanced or metastatic thyroid cancer.
[Report]
This is the latest version of this item.
![[thumbnail of Greenhalgh_2017.pdf]](https://livrepository.liverpool.ac.uk/style/images/fileicons/text.png) |
Text
Greenhalgh_2017.pdf - Unspecified Download (4MB) |
Official URL: https://www.nice.org.uk/guidance/ta535/documents/c...
| Item Type: | Report |
|---|---|
| Depositing User: | Symplectic Admin |
| Date Deposited: | 18 Feb 2019 09:48 |
| Last Modified: | 19 Jan 2023 01:03 |
| Related URLs: | |
| URI: | https://livrepository.liverpool.ac.uk/id/eprint/3033026 |
Available Versions of this Item
-
Sorafenib and lenvatinib for treating advanced or metastatic thyroid cancer. (deposited 18 Feb 2019 09:26)
- Sorafenib and lenvatinib for treating advanced or metastatic thyroid cancer. (deposited 18 Feb 2019 09:48) [Currently Displayed]
Share
Share
Share
CORE (COnnecting REpositories)